A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma

Name: A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
License: Public Domain

Dana-Farber Cancer Institute

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

brain-cancer

brain cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 141020
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.